CD4 and myeloid sarcoma: Although current evidence suggests a more important role for CD4+ T cells in MS pathogenesis, the high abundance of CD8+ T cells in MS lesions and oligoclonal TCR repertoires suggest that these expand and may be antigen-specific (58, 59).